Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency

Nephrology Dialysis Transplantation

Volumn 22, Issue 5, 2007, Pages 1390-1398

  Sajgure, Atul ^a   Choudhury, Arindam ^b   Ahmed, Ziauddin ^c   Choudhury, Devasmita ^d  

^a Sahyadri Speciality Hospital Pune   (India)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Dialysis; Fistulas; Grafts; Patency; Thrombosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POLITEF;

ADULT; ARTERIOVENOUS FISTULA; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; FISHER EXACT TEST; GRAFT FAILURE; GRAFT PATENCY; GRAFT SURVIVAL; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; PATIENT CODING; POLITEF IMPLANT; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STUDENT T TEST; THROMBOSIS; UNIVARIATE ANALYSIS; VASCULAR ACCESS;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIOVENOUS SHUNT, SURGICAL; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; VASCULAR PATENCY;

EID: 34447525317     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl821     Document Type: Article

References (16)

1. Schwab SJ, Harrington JT, Singh A et al. Vascular access for haemodialysis. Kidney Int 1999; 55: 2078-2090
2. Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in haemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 1989; 80: 1726-1736
3. Roy-Chaudhury P, Kelly BS, Miller MA et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001; 59: 2325-2334
4. Hehrlein C. How do AV fistulae lose function? The roles of haemodynamics, vascular remodelling, and intimal hyperplasia. Nephrol Dial Transplant 1995; 10: 1287-1290
5. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90: 456-461
6. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994; 330: 1431-1438
7. Nakamura Y, Nakamura K, Matsukura T, Nakamura K. Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril. J Hypertens 1988; 6: 105-110
8. Executive summary.United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis 1999; 34: S9-S19
9. Diskin CJ, Stokes TJ, Thomas SG et al. An analysis of the effect of routine medications on haemodialysis vascular access survival. Nephron 1998; 78: 365-368
10. Gradzki R, Dhingra RK, Port FK, Roys E, Weitzel WF, Messana JM. Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts. Am J Kidney Dis 2001; 38: 1240-1244
11. Schmitz PG, McCloud LK, Reikes ST, Leonard CL, Gellens ME. Prophylaxis of haemodialysis graft thrombosis with fish oil: Double-blind, randomized, prospective trial. J Am Soc Nephrol 2002; 13: 184-190
12. Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in haemodialysis patients. Kidney Int 2003; 63: 346-352
13. Sone M, Moriyama T, Mifune N, Shirota S, Omae K, Nishida E, Ogawa T. Nihei H. Angiotensin II inhibition prevents the occlusion of arteriovenous fistula in hemodialysis patients: A prospective case control study. J Am Soc Nephrol 2000, 11: 197A
14. Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW. Association between vascular access failure and the use of specific drugs: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2003; 40: 1255-1263
15. Garrancho JM, Kirchgessner J, Arranz M et al. Haemoglobin level and vascular access survival in haemodialysis patients. Nephrol Dial Transplant 2005; 20: 2453-2457
16. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM. Anti-platelet therapy in graft thrombosis: Results of a prospective, randomized, double-blind study. Kidney Int 1994; 45: 1477-1483